Compare · DXCM vs PLSM
DXCM vs PLSM
Side-by-side comparison of DexCom Inc. (DXCM) and Pulsenmore Ltd. (PLSM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DXCM and PLSM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- DXCM is the larger of the two at $31.90B, about 1994.0x PLSM ($16.0M).
- Over the past year, DXCM is up 7.7% and PLSM is down 61.1% - DXCM leads by 68.8 points.
- PLSM has been more active in the news (12 items in the past 4 weeks vs 8 for DXCM).
- DXCM has more recent analyst coverage (25 ratings vs 0 for PLSM).
- Company
- DexCom Inc.
- Pulsenmore Ltd.
- Price
- $84.49-3.84%
- $2.45+0.82%
- Market cap
- $31.90B
- $16.0M
- 1M return
- -0.34%
- -26.87%
- 1Y return
- +7.73%
- -61.11%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- News (4w)
- 8
- 12
- Recent ratings
- 25
- 0
DexCom Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Latest DXCM
- Dexcom Announces Upcoming Conference Presentation
- EVP Chief People & Culture Off Stern Sadie sold $226,669 worth of shares (2,565 units at $88.37) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 126,043 units (SEC Form 4)
- EVP Chief Legal Compliance Off Brown Michael Jon covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 101,502 units (SEC Form 4) (withholding obligation)
- EVP, Chief Financal Officer Sylvain Jereme M covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.96% to 150,390 units (SEC Form 4) (withholding tax)
- President, CEO, and Director Leach Jacob Steven covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.35% to 418,908 units (SEC Form 4) to satisfy withholding tax
- EVP Chief People & Culture Off Stern Sadie covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 128,608 units (SEC Form 4) (withholding tax)
- Executive Chair Sayer Kevin R sold $2,408,242 worth of shares (26,756 units at $90.01) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 302,214 units (SEC Form 4)
- EVP Chief Legal Compliance Off Brown Michael Jon sold $156,281 worth of shares (1,700 units at $91.93) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 102,953 units (SEC Form 4)
- Director Augustinos Nicholas gifted 1,075 shares (SEC Form 4)
- Director Heller Bridgette P sold $89,349 worth of shares (1,012 units at $88.29) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 29,570 units (SEC Form 4)
Latest PLSM
- SEC Form 6-K filed by Pulsenmore Ltd.
- Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring
- SEC Form EFFECT filed by Pulsenmore Ltd.
- SEC Form POS AM filed by Pulsenmore Ltd.
- SEC Form S-8 filed by Pulsenmore Ltd.
- SEC Form 6-K filed by Pulsenmore Ltd.
- Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
- Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026
- SEC Form 6-K filed by Pulsenmore Ltd.
- Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring